Palatal and oral manifestations of muenke syndrome (FGFR3-related craniosynostosis)

Journal of Craniofacial Surgery

Volumn 23, Issue 3, 2012, Pages 664-668

  Agochukwu, Nneamaka Barbara ^a,b   Solomon, Benjamin D ^a   Doherty, Emily S ^c   Muenke, Maximilian ^a  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c Carilion Pediatric Clinic   (United States)

Author keywords

cleft lip and palate craniosynostosis; FGFR craniosynostosis palate; FGFR3 craniosynostosis; Muenke syndrome; palate Muenke syndrome

Indexed keywords

EID: 85027923600     PISSN: 10492275     EISSN: None     Source Type: Journal    
DOI: 10.1097/SCS.0b013e31824db8bb     Document Type: Conference Paper

References (57)

1. Dixon MJ, Marazita ML, Beaty TH, et al. Cleft lip and palate: understanding genetic and environmental influences. Nat Rev Genet 2011;12:167-178
2. Vanderas AP. Incidence of cleft lip, cleft palate, and cleft lip and palate among races: a review. Cleft Palate J 1987;24:216-225
3. Croen LA, Shaw GM, Wasserman CR, et al. Racial and ethnic variations in the prevalence of orofacial clefts in California, 1983-1992. Am J Med Genet 1998;79:42-47
4. Tolarova MM, Cervenka J. Classification and birth prevalence of orofacial clefts. Am J Med Genet 1998;75:126-137
5. Murray JC, Daack-Hirsch S, Buetow KH, et al. Clinical and epidemiologic studies of cleft lip and palate in the Philippines. Cleft Palate Craniofac J 1997;34:7-10
6. Beaty TH, Murray JC, Marazita ML, et al. A genome-wide association study of cleft lip with and without cleft palate identifies risk variants near MAFB and ABCA4. Nature Genet 2010;42:525-529
7. Mossey P, Little J, Munger RG, et al. Cleft lip and palate. Lancet 2009;374:1773-1785
8. Christensen K, Mitchell LE. Familial recurrence-pattern analysis of nonsyndromic isolated cleft palateVa Danish Registry study. Am J Hum Genet 1996;58:182-190
9. Jones MC. Etiology of facial clefts: prospective evaluation of 428 patients. Cleft Palate J 1988;25:16-20
10. FitzPatrick DR, Raine PA, Boorman JG. Facial clefts in the west of Scotland in the period 1980-1984: epidemiology and genetic diagnoses. J Med Genet 1994;31:126-129
11. Marazita ML, Field LL, Cooper ME, et al. Nonsyndromic cleft lip with or without cleft palate in China: assessment of candidate regions. Cleft Palate Craniofac J 2002;39:149-156
12. Francis-West P, Ladher R, Barlow A, et al. Signalling interactions during facial development. Mech Dev 1998;75:3-28
13. Schutte BC, Murray JC. The many faces and factors of orofacial clefts. Hum Mol Genet 1999;8:1853-1859
14. Spritz RA. The genetics and epigenetics of orofacial clefts. Curr Opin Pediatr 2001;13:556-560
15. Stanier P, Moore GE. Genetics of cleft lip and palate: syndromic genes contribute to the incidence of non-syndromic clefts. Hum Mol Genet 2004;13 spec no 1:R73-R81
16. Jugessur A, Farlie PG, Kilpatrick N. The genetics of isolated orofacial clefts: from genotypes to subphenotypes. Oral Dis 2009;15:437-453
17. Sahoo T, Theisen A, Sanchez-Lara PA, et al. Microdeletion 20p12.3 involving BMP2 contributes to syndromic forms of cleft palate. Am J Med Genet A 2011;155:1646-1653
18. Szabo-Rogers HL, Geetha-Loganathan P, Nimmagadda S, et al. FGF signals from the nasal pit are necessary for normal facial morphogenesis. Dev Biol 2008;318:289-302
19. Zhang X, Ibrahimi OA, Olsen SK. Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family. J Biol Chem 2006;281:15694-15700
20. Bachler M, Neubüser A. Expression of members of the FGF family and their receptors during midfacial development. Mech Dev 2001;100:313-316
21. Crossley PH, Martin GR. The mouse FGF8 gene encodes a family of polypeptides and is expressed in regions that direct outgrowth and patterning in the developing embryo. Development 1995;121:439-451
22. Havens BA, Rodgers B, Mina M. Tissue-specific expression of FGFR2b and FGFR2c isoforms, FGF10 and FGF9 in the developing chick mandible. Arch Oral Biol 2006;51:134-145
23. Karabagli H, Karabagli P, Ladher RK, et al. Survey of fibroblast growth factor expression during chick organogenesis. Anat Rec 2002;268:1-6
24. Kettunen P, Thesleff I. Expression and function of FGFs-4, -8, and -9 suggest functional redundancy and repetitive use as epithelial signals during tooth morphogenesis. Dev Dyn 1998;211:256-268
25. Rice R, Spencer-Dene B, Connor EC, et al. Disruption of FGF10/FGFR2b-coordinated epithelial-mesenchymal interactions causes cleft palate. J Clin Invest 2004;113:1692-1700
26. Ohuchi H, Kimura S, Watamoto M, et al. Involvement of fibroblast growth factor (FGF)18-FGF8 signaling in specification of left-right asymmetry and brain and limb development of the chick embryo. Mech Dev 2000;95:55-66
27. McGonnell IM, Clarke JD, Tickle C. Fate map of the developing chick face: analysis of expansion of facial primordia and establishment of the primary palate. Dev Dyn 1998;212:102-118
28. Richman JM, Herbert M, Matovinovic E, et al. Effect of fibroblast growth factors on outgrowth of facial mesenchyme. Dev Biol 1997;189:135-147
29. Wilke TA, Gubbels S, Schwartz J, et al. Expression of fibroblast growth factor receptors (FGFR1, FGFR2, FGFR3) in the developing head and face. Dev Dyn 1997;210:41-52
30. Matovinovic E, Richman JM. Epithelium is required for maintaining FGRF-2 expression levels in facial mesenchyme of the developing chick embryo. Dev Dyn 1997;210:407-416
31. Stoler JM, Rosen H, Desai U, et al. Cleft palate in Pfeiffer syndrome. J Craniofac Surg 2009;20:1375-1377
32. Kreiborg S, Cohen MM Jr. The oral manifestations of Apert syndrome. J Craniofac Genet Dev Biol 1992;12:41-48
33. Peterson SJ, Pruzansky S. Palatal anomalies in the syndromes of Apert and Crouzon. Cleft Palate J 1974;11:394-403
34. Reardon W, Wilkes D, Rutland P, et al. Craniosynostosis associated with FGFR3 pro250arg mutation results in a range of clinical presentations including unisutural sporadic craniosynostosis. J Med Genet 1997;34:632-636
35. Stoler JM, Rogers GF, Mulliken JB. The frequency of palatal anomalies in Saethre-Chotzen syndrome. Cleft Palate Craniofac J 2009;46:280-284
36. Connerney J, Andreeva V, Leshem Y, et al. Twist1 dimer selection regulates cranial suture patterning and fusion. Dev Dyn 2006;235:1345-1357
37. Connerney J, Andreeva V, Leshem Y, et al. Twist1 homodimers enhance FGF responsiveness of the cranial sutures and promote suture closure. Dev Biol 2008;318:323-334
38. Rice DP, Aberg T, Chan Y, et al. Integration of FGF and TWIST in calvarial bone and suture development. Development 2000;127:1845-1855
39. Hornik C, Brand-Saberi B, Rudloff S, et al. Twist is an integrator of SHH, FGF, and BMP signaling. Anat Embryol (Berl) 2004;209:31-39
40. Boulet SL, Rasmussen SA, Honein MA. A population-based study of craniosynostosis in metropolitan Atlanta, 1989-2003. Am J Med Genet A 2008;146A:984-991
41. Bellus G, McIntosh I, Smith EA, et al. A recurrent mutation in the tyrosine kinase domain of fibroblast growth factor receptor 3 causes hypochondroplasia. Nat Genet 1995;10:357-359
42. Muenke M, Gripp KW, McDonald-McGinn DM, et al. A unique point mutation in the fibroblast growth factor receptor 3 gene (FGFR3) defines a new craniosynostosis syndrome. Am J Hum Genet 1997;60:555-564
43. Wilkie AO, Byren JC, Hurst JA, et al. Prevalence and complications of single gene and chromosomal disorders in craniosynostosis. Pediatrics 2010;126:e391-e400
44. Hajihosseini MK, Duarte R, Pegrum J, et al. Evidence that FGF10 contributes to the skeletal and visceral defects of an Apert syndrome mouse model. Dev Dyn 2009;238:376-385
45. Abdel-Salam GM, Flores-Sarnat L, El-Ruby MO, et al. Muenke syndrome with pigmentary disorder and probable hemimegalencephaly: an expansion of the phenotype. Am J Med Genet A 2011 155A 207-214
46. Barbosa M, Almeida MR, Reis-Lima M, et al. Muenke syndrome with osteochondroma. Am J Med Genet Part A 2009;149A:260-261
47. Baynam GS, Goldblatt J. A child with an FGFR3 mutation, a laterality disorder and an hepatoblastoma: novel associations and possible gene-environment interactions. Twin Res Hum Genet 2010; 13:297-300
48. Doherty ES, Lacbawan F, Hadley DW, et al. Muenke syndrome (FGFR3-related craniosynostosis): expansion of the phenotype and review of the literature. Am J Med Genet A 2007;143A: 3204-3215
49. de Jong T, Mathijssen IM, Hoogeboom AJ Additional phenotypic features of Muenke syndrome in 2 Dutch families. J Craniofac Surg 2011 22 p.571-575
50. Lowry RB, Jabs EW, Graham GE, et al. Syndrome of coronal craniosynostosis, Klippel-Feil anomaly, and Sprengel shoulder with and without Pro250Arg mutation in the FGFR3 gene. Am J Med Genet 2001;104:112-119
51. Ranger A, Chaudhary N, Rau J, et al. Coronal synostosis syndrome (Muenke syndrome): the value of genetic testing versus clinical diagnosis. J Craniofac Surg 2011;22:187-190
52. ReardonW,Wilkes D, Rutland P, et al. Craniosynostosis associated with FGFR3 pro250arg mutation results in a range of clinical presentations including unisutural sporadic craniosynostosis. J Med Genet 1997;34:632-636
53. Roscioli T, Flanagan S, Mortimore RJ, et al. Premature calvarial synostosis and epidermal hyperplasia (Beare-Stevenson syndrome-like anomalies) resulting from a P250R missense mutation in the gene encoding fibroblast growth factor receptor 3. Am J Med Genet 2001;101:187-194
54. Sabatino G, Di Rocco F, Zampino G, et al. Muenke syndrome. Childs Nerv Syst 2004;20:297-301
55. Ibrahimi OA, Zhang F, Eliseenkova AV, et al. Biochemical analysis of pathogenic ligand-dependent FGFR2 mutations suggests distinct pathophysiological mechanisms for craniofacial and limb abnormalities. Hum Mol Genet 2004;13:2313-2324
56. Stevenson RE, Hall JG, Goodman RM. Human Malformations and Related Anomalies. Vol II. New York, NY: Oxford University Press, 1993:377
57. Escobar LF, Hiett AK, Marnocha A. Significant phenotypic variability of Muenke syndrome in identical twins. Am J Med Genet A 2009;149A:1273-1276